Cetuximab-Modified Human Serum Albumin Nanoparticles Co-Loaded with Doxorubicin and MDR1 siRNA for the Treatment of Drug-Resistant Breast Tumors

Xin Yang,1– 3 Yifan Wang,1– 3 Si Chen,1– 3 Shuang Zhang,1– 3 Chunying Cui1– 3 1School of Pharmaceutical Sciences, Capital Medical University, Beijing, 100069, People’s Republic of China; 2Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China, Beijing, 100069, Peopl...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yang X, Wang Y, Chen S, Zhang S, Cui C
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
hsa
mdr
Acceso en línea:https://doaj.org/article/51ca6953ebe74948ac92718055841df8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!